Overview of Humira Registry Medical Research Study
The Humira Registry Medical Research Study looking to enroll individuals who are currently prescribed and taking Humira for Ulcerative Colitis. Our site staff will collect
important information to evaluate the long-term safety of HUMIRA® inmoderately to severely active UC adult patients (18 years of age or older) who are treatedper routine clinical practice.
What is Humira?
Humira was initially approved by the FDA in 2002 to treat Rheumatoid Arthritis. Since
Humira’s introduction to market, it has been approved to treat several autoimmune
diseases with ulcerative colitis being added to the list in 2012. Humira therapy has a
well-established and well described safety profile based onextensive post-marketing
experience and continued clinical trial patient exposure since the first approved
indication in 2002 for rheumatoid arthritis
You may be eligible to take part in the study if you:
An adult patient (18 years of age or older) who has been prescribed HUMIRA® for moderately to severely active UC
You may be compensated for time and travel, up to $50 for each completed study visit
If you have been diagnosed with Ulcerative colitis and are currently being treated with Humira, contact us today to learn more about our current study opportunities for this diagnosis.
Signup online by completing contact form below, or email our Administrative Coordinator, Shaniquiea Sumpter at email@example.com. You can also call us toll free at 1.888.574.INVO or text us at 803.291.4972